Filing Flows › Industries › Industrials › Services-Commercial Physical & Biological Research
Services-Commercial Physical & Biological Research SIC 8731
12 companies filing with the SEC under SIC 8731. Median revenue growth +9% year on year in Q3 2026 (middle half +3% to +12%, 7 companies). The growth model expects the industry's combined revenue to grow +12% in Q3 2026. 1 customer or supplier links named in annual reports.
Money flow: where the industry's revenue goes
Drawn in the browser: an estimate of where the industry's revenue goes — what it buys from other industries, the pay that reaches households, taxes and profit — beside its filed cash flow, two tiers of suppliers and its capital spending by kind of asset.
Open the industry: growth distribution, money flow, network →
Who sells to whom
Customers and suppliers named in the companies' annual reports; the share is of the supplier's revenue.
- LLY → INCY
Growth model
Industry revenue, the same companies year on year; 80% ranges. Fitted on SEC filings and tested out of sample (how).
| Quarter | Growth Y/Y | Revenue | 80% range |
|---|---|---|---|
| Q3 2026 | +12.3% | $8.1B | $7.5B – $8.6B |
| Q4 2026 | +11.6% | $8.5B | $7.8B – $9.2B |
| Q1 2027 | +10.8% | $8.0B | $7.3B – $8.6B |
| Q2 2027 | +10.2% | $8.6B | $7.9B – $9.3B |
Capital spending and supply chain →
Companies
| Company | Quarterly revenue | Y/Y | Stage |
|---|---|---|---|
| IQV IQVIA Holdings | $4.4B | +8% | mature |
| INCY Incyte | $1.6B | +14% | deceleration |
| CRL Charles River Laboratories International | $983M | -2% | mature |
| MEDP Medpace Holdings | $716M | +9% | deceleration |
| NRC NRC Health | $38.4M | +11% | transition |
| MXCT Maxcyte | $7.3M | — | contraction |
| FOXO Foxo Technologies | $4.7M | — | contraction |
| OABI OmniAb | $4.0M | +78% | deceleration |
| BIAF bioAffinity Technologies | $1.1M | -26% | contraction |
| ABSI Absci | $318K | — | transition |
| ONMD OneMedNet | $292K | — | reacceleration |
| ISPC iSpecimen | $152K | — | transition |
Growth from positive, comparable quarterly revenue as filed; industries are SEC Standard Industrial Classification codes. Data Nov 8, 2026.